These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18718436)

  • 1. Harm reduction drug policy.
    Voth EA
    Lancet Infect Dis; 2008 Sep; 8(9):528; author reply 528-9. PubMed ID: 18718436
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 3. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NICE endorses use of needle exchange scheme to minimise infection risk.
    Cole A
    BMJ; 2009 Feb; 338():b771. PubMed ID: 19237409
    [No Abstract]   [Full Text] [Related]  

  • 5. [Harm reduction policy related to drug use: the needles exchange programs].
    Emmanuelli J
    Med Sci (Paris); 2004 May; 20(5):599-603. PubMed ID: 15190482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 7. Australia. First, do harm reduction.
    Science; 2014 Jul; 345(6193):156-8. PubMed ID: 25013058
    [No Abstract]   [Full Text] [Related]  

  • 8. Making the case for harm reduction programs for injection drug users.
    Kulikowski J; Linder E
    Nursing; 2018 Jun; 48(6):46-51. PubMed ID: 29794629
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious Diseases and Injection Drug Use: Public Health Burden and Response.
    Levitt A; Mermin J; Jones CM; See I; Butler JC
    J Infect Dis; 2020 Sep; 222(Suppl 5):S213-S217. PubMed ID: 32877539
    [No Abstract]   [Full Text] [Related]  

  • 11. The Latin American harm reduction network (RELARD): successes and challenges.
    Bueno R
    Int J Drug Policy; 2007 Mar; 18(2):145-7. PubMed ID: 17689358
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C prevention and true harm reduction.
    Madden A; Cavalieri W
    Int J Drug Policy; 2007 Oct; 18(5):335-7. PubMed ID: 17854719
    [No Abstract]   [Full Text] [Related]  

  • 13. The transition to harm reduction: understanding the role of non-governmental organisations in Malaysia.
    Narayanan S; Vicknasingam B; Robson NM
    Int J Drug Policy; 2011 Jul; 22(4):311-7. PubMed ID: 21300533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Harm reduction--coming of age": a local movement with global impact.
    Stimson GV
    Int J Drug Policy; 2007 Mar; 18(2):67-9. PubMed ID: 17689346
    [No Abstract]   [Full Text] [Related]  

  • 15. Harm reduction and control of HIV in IDUs in France.
    Carrieri MP; Spire B
    Lancet; 2008 Aug; 372(9637):448. PubMed ID: 18692713
    [No Abstract]   [Full Text] [Related]  

  • 16. Supervised consumption rooms: the French Paradox.
    Jauffret-Roustide M; Pedrono G; Beltzer N
    Int J Drug Policy; 2013 Nov; 24(6):628-30. PubMed ID: 23777651
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlling disease transmission in injection drug users.
    Kane B
    Ann Intern Med; 1999 Mar; 130(6):541-4. PubMed ID: 10075630
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe exchange.
    Jacobs R; Toynton P
    N J Med; 2003 Sep; 100(9 Suppl):55-9; quiz 79-80. PubMed ID: 14556605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.